img

Global Smoking Cessation Aids Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Smoking Cessation Aids Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Smoking Cessation Aids market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Smoking Cessation Aids market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Smoking Cessation Aids in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
NRT Inhaler
NRT Patch
Spray
Drug
Electronic Cigarettes
Other

Market Snapshot, By Application
Pharmacy
Supermarket
Hospital
Other

Main Market Players Analyzed in this report, including
Takeda Pharmaceuticals
Roche
Reckitt Benckiser
Pfizer
Novartis
NJOY
Johnson and Johnson
GlaxoSmithKline
Cipla
Bayer

The study objectives of this report are
To study and analyze the global Smoking Cessation Aids market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Smoking Cessation Aids market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Smoking Cessation Aids manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Smoking Cessation Aids market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Smoking Cessation Aids submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Smoking Cessation Aids are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Smoking Cessation Aids Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Smoking Cessation Aids Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Smoking Cessation Aids

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Smoking Cessation Aids Sales Channel and Distributors Analysis
3.3.1 Smoking Cessation Aids Sales Channel
3.3.2 Smoking Cessation Aids Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Pharmacy
3.4.2 Major Buyers in Supermarket
3.5 Smoking Cessation Aids Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Smoking Cessation Aids Type Introduction
4.1.1 NRT Inhaler
4.1.2 NRT Patch
4.1.3 Spray
4.1.4 Drug
4.1.5 Electronic Cigarettes
4.1.6 Other
4.2 Global Smoking Cessation Aids Sales by Type 2016-2021
4.3 Global Smoking Cessation Aids Revenue by Type 2016-2021
4.4 Global Smoking Cessation Aids Price by Type 2016-2021

5 Market Segment: by Application
5.1 Smoking Cessation Aids Type Introduction
5.1.1 Pharmacy
5.1.2 Supermarket
5.1.3 Hospital
5.1.3 Other
5.2 Global Smoking Cessation Aids Sales by Application 2016-2021
5.3 Global Smoking Cessation Aids Revenue by Application 2016-2021
5.4 Global Smoking Cessation Aids Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Smoking Cessation Aids Market by Region
6.1.1 Global Smoking Cessation Aids Sales by Regions
6.1.2 Global Smoking Cessation Aids Revenue by Regions
6.2 North America Smoking Cessation Aids Market 2016-2021
6.3 Europe Smoking Cessation Aids Market 2016-2021
6.4 Asia Pacific Smoking Cessation Aids Market 2016-2021
6.5 South America Smoking Cessation Aids Market 2016-2021
6.6 Middle East and Africa Smoking Cessation Aids Market 2016-2021

7 North America
7.1 North America Smoking Cessation Aids Market by Country 2016-2021
7.1.1 North America Smoking Cessation Aids Sales by Country
7.1.2 North America Smoking Cessation Aids Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Smoking Cessation Aids Market by Country 2016-2021
8.1.1 Europe Smoking Cessation Aids Sales by Country
8.1.2 Europe Smoking Cessation Aids Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Smoking Cessation Aids Market by Country 2016-2021
9.1.1 Asia Pacific Smoking Cessation Aids Sales by Country
9.1.2 Asia Pacific Smoking Cessation Aids Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Smoking Cessation Aids Market by Country 2016-2021
10.1.1 South America Smoking Cessation Aids Sales by Country
10.1.2 South America Smoking Cessation Aids Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Smoking Cessation Aids Market by Country 2016-2021
11.1.1 Middle East and Africa Smoking Cessation Aids Sales by Country
11.1.2 Middle East and Africa Smoking Cessation Aids Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Company Information
12.1.2 Takeda Pharmaceuticals Smoking Cessation Aids Product Portfolio, Specification and Application
12.1.3 Takeda Pharmaceuticals Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Takeda Pharmaceuticals Key Development
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Smoking Cessation Aids Product Portfolio, Specification and Application
12.2.3 Roche Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Roche Key Development
12.3 Reckitt Benckiser
12.3.1 Reckitt Benckiser Company Information
12.3.2 Reckitt Benckiser Smoking Cessation Aids Product Portfolio, Specification and Application
12.3.3 Reckitt Benckiser Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Reckitt Benckiser Key Development
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Smoking Cessation Aids Product Portfolio, Specification and Application
12.4.3 Pfizer Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Pfizer Key Development
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Smoking Cessation Aids Product Portfolio, Specification and Application
12.5.3 Novartis Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Novartis Key Development
12.6 NJOY
12.6.1 NJOY Company Information
12.6.2 NJOY Smoking Cessation Aids Product Portfolio, Specification and Application
12.6.3 NJOY Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 NJOY Key Development
12.7 Johnson and Johnson
12.7.1 Johnson and Johnson Company Information
12.7.2 Johnson and Johnson Smoking Cessation Aids Product Portfolio, Specification and Application
12.7.3 Johnson and Johnson Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 NJOY Key Development
12.9 Cipla
12.9.1 Cipla Company Information
12.9.2 Cipla Smoking Cessation Aids Product Portfolio, Specification and Application
12.9.3 Cipla Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Cipla Key Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Information
12.8.2 GlaxoSmithKline Smoking Cessation Aids Product Portfolio, Specification and Application
12.8.3 GlaxoSmithKline Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 GlaxoSmithKline Key Development

13 Global Smoking Cessation Aids Market Forecast by Region by Type and by Application
13.1 Global Smoking Cessation Aids Sales, Revenue Forecast 2022-2027
13.2 Global Smoking Cessation Aids Forecast by Regions
13.2.1 Global Smoking Cessation Aids Sales Forecast by Region 2022-2027
13.2.2 Global Smoking Cessation Aids Revenue Forecast by Region 2022-2027
13.3 Global Smoking Cessation Aids Forecast by Type
13.3.1 Global Smoking Cessation Aids Sales Forecast by Type 2022-2027
13.3.2 Global Smoking Cessation Aids Revenue Forecast by Type 2022-2027
13.3.3 Global Smoking Cessation Aids Price Forecast by Type 2022-2027
13.4 Global Smoking Cessation Aids Forecast by Application
13.4.1 Global Smoking Cessation Aids Sales Forecast by Application 2022-2027
13.4.2 Global Smoking Cessation Aids Revenue Forecast by Application 2022-2027
13.4.3 Global Smoking Cessation Aids Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Smoking Cessation Aids Production Specifications
Table 2: Drivers in Smoking Cessation Aids Market
Table 3: Restraints Smoking Cessation Aids Market
Table 4: Opportunity in Smoking Cessation Aids Market
Table 5: Comparion of Alternative and Smoking Cessation Aids
Table 6: Smoking Cessation Aids Raw Materials Key Suppliers List
Table 7: Smoking Cessation Aids Distributors List
Table 8: Smoking Cessation Aids Major Buyers in Pharmacy
Table 9: Smoking Cessation Aids Major Buyers in Supermarket
Table 10: Smoking Cessation Aids Major Buyers in Hospital
Table 11: Global Smoking Cessation Aids Sales (K Units) by Type 2016-2021
Table 12: Global Smoking Cessation Aids Sales Market Share by Type 2016-2021
Table 13: Global Smoking Cessation Aids Revenue (Million USD) by Type 2016-2021
Table 14: Global Smoking Cessation Aids Revenue Market Share by Type 2016-2021
Table 15: Global Smoking Cessation Aids Price by Type 2016-2021
Table 16: Global Smoking Cessation Aids Sales (K Units) by Application 2016-2021
Table 17: Global Smoking Cessation Aids Sales Market Share by Application 2016-2021
Table 18: Global Smoking Cessation Aids Revenue (Million USD) by Application 2016-2021
Table 19: Global Smoking Cessation Aids Revenue Market Share by Application 2016-2021
Table 20: Global Smoking Cessation Aids Price by Application 2016-2021
Table 21: Global Smoking Cessation Aids Sales (K Units) by Region 2016-2021
Table 22: Global Smoking Cessation Aids Sales Market Share by Region 2016-2021
Table 23: Global Smoking Cessation Aids Revenue (Million USD) by Region 2016-2021
Table 24: Global Smoking Cessation Aids Revenue Market Share by Region 2016-2021
Table 25: North America Smoking Cessation Aids Sales (K Units) by Country 2016-2021
Table 26: North America Smoking Cessation Aids Sales Market Share by Country 2016-2021
Table 27: North America Smoking Cessation Aids Revenue (Million USD) by Country 2016-2021
Table 28: North America Smoking Cessation Aids Revenue Market Share by Country 2016-2021)
Table 29: Europe Smoking Cessation Aids Sales (K Units) by Country 2016-2021
Table 30: Europe Smoking Cessation Aids Sales Market Share by Country 2016-2021
Table 31: Europe Smoking Cessation Aids Revenue (Million USD) by Country 2016-2021
Table 32: Europe Smoking Cessation Aids Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Smoking Cessation Aids Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Smoking Cessation Aids Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Smoking Cessation Aids Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Smoking Cessation Aids Revenue Market Share by Country 2016-2021)
Table 37: South America Smoking Cessation Aids Sales (K Units) by Country 2016-2021
Table 38: South America Smoking Cessation Aids Sales Market Share by Country 2016-2021
Table 39: South America Smoking Cessation Aids Revenue (Million USD) by Country 2016-2021
Table 40: South America Smoking Cessation Aids Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Smoking Cessation Aids Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Smoking Cessation Aids Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Smoking Cessation Aids Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Smoking Cessation Aids Revenue Market Share by Country 2016-2021)
Table 45 Takeda Pharmaceuticals Company Information
Table 46 Takeda Pharmaceuticals Smoking Cessation Aids Product Portfolio, Specification and Application
Table 47 Takeda Pharmaceuticals Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Roche Company Information
Table 49 Roche Smoking Cessation Aids Product Portfolio, Specification and Application
Table 50 Roche Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Reckitt Benckiser Company Information
Table 52 Reckitt Benckiser Smoking Cessation Aids Product Portfolio, Specification and Application
Table 53 Reckitt Benckiser Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Pfizer Company Information
Table 55 Pfizer Smoking Cessation Aids Product Portfolio, Specification and Application
Table 56 Pfizer Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Novartis Company Information
Table 58 Novartis Smoking Cessation Aids Product Portfolio, Specification and Application
Table 59 Novartis Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 NJOY Company Information
Table 61 NJOY Smoking Cessation Aids Product Portfolio, Specification and Application
Table 62 NJOY Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Johnson and Johnson Company Information
Table 64 Johnson and Johnson Smoking Cessation Aids Product Portfolio, Specification and Application
Table 65 Johnson and Johnson Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 GlaxoSmithKline Company Information
Table 67 GlaxoSmithKline Smoking Cessation Aids Product Portfolio, Specification and Application
Table 68 GlaxoSmithKline Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Cipla Company Information
Table 70 Cipla Smoking Cessation Aids Product Portfolio, Specification and Application
Table 71 Cipla Smoking Cessation Aids Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Smoking Cessation Aids Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Smoking Cessation Aids Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Smoking Cessation Aids Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Smoking Cessation Aids Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Smoking Cessation Aids Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Smoking Cessation Aids Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Smoking Cessation Aids Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Smoking Cessation Aids Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Smoking Cessation Aids Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Smoking Cessation Aids Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Smoking Cessation Aids Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Smoking Cessation Aids Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Smoking Cessation Aids Picture
Figure 2: Global Smoking Cessation Aids Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Smoking Cessation Aids Supply Chain Analysis
Figure 5: Smoking Cessation Aids Manufacturing Cost Structure Analysis
Figure 6: Product Picture of NRT Inhaler
Figure 7: Product Picture of NRT Patch
Figure 8: Global Smoking Cessation Aids Sales Market Share by Type, 2020
Figure 9: Global Smoking Cessation Aids Revenue Market Share by Type, 2020
Figure 10: Smoking Cessation Aids in Pharmacy
Figure 11: Global Smoking Cessation Aids Market: Pharmacy 2016-2021
Figure 12: Smoking Cessation Aids in Supermarket
Figure 13: Global Smoking Cessation Aids Market: Supermarket 2016-2021
Figure 14: Global Smoking Cessation Aids Sales Market Share by Application, 2020
Figure 15: Global Smoking Cessation Aids Revenue Market Share by Application, 2020
Figure 16: Global Smoking Cessation Aids Sales Market Share by Region 2016-2021
Figure 17: Global Smoking Cessation Aids Revenue Market Share by Region 2016-2021
Figure 18: North America Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 19: North America Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 20: Europe Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 21: Europe Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 24: South America Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 25: South America Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 28: North America Smoking Cessation Aids Sales Market Share by Country, 2020
Figure 29: North America Smoking Cessation Aids Revenue Market Share by Country, 2020
Figure 30: United States Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 31: United States Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 32: Canada Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 33: Canada Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 35: Mexico Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 36: Europe Smoking Cessation Aids Sales Market Share by Country, 2020
Figure 37: Europe Smoking Cessation Aids Revenue Market Share by Country, 2020
Figure 38: Germany Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 39: Germany Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 40: France Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 41: France Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 42: UK Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 43: UK Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 44: Italy Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 45: Italy Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 46: Russia Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 46: Russia Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 47: Spain Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 48: Spain Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Smoking Cessation Aids Sales Market Share by Country, 2020
Figure 50: Asia Pacific Smoking Cessation Aids Revenue Market Share by Country, 2020
Figure 51: China Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 52: China Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 53: Japan Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 54: Japan Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 55: Korea Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 56: Korea Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 59: India Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 60: India Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 61: Australia Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 62: Australia Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 63: South America Smoking Cessation Aids Sales Market Share by Country, 2020
Figure 64: South America Smoking Cessation Aids Revenue Market Share by Country, 2020
Figure 65: Brazil Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 66: Brazil Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 68: Argentina Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 70: Colombia Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Smoking Cessation Aids Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Smoking Cessation Aids Revenue Market Share by Country, 2020
Figure 73: Turkey Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 74: Turkey Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Smoking Cessation Aids Sales (K Units) Status 2016-2021
Figure 78: South Africa Smoking Cessation Aids Revenue (Million USD) Status 2016-2021
Figure 79: Takeda Pharmaceuticals Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 80: Roche Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 81: Reckitt Benckiser Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 82: Pfizer Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 83: Novartis Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 84: NJOY Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 85: Johnson and Johnson Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 86: GlaxoSmithKline Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 87: Cipla Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 88: Bayer Smoking Cessation Aids Revenue Market Share Globally (2019-2021)
Figure 89: Global Smoking Cessation Aids Sales (K Units) Forecast (2022-2027)
Figure 90: Global Smoking Cessation Aids Sales (K Units) Forecast (2022-2027)